Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial

Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling

(2010) R. Graham Barr et al.   NEW ENGLAND JOURNAL OF MEDICINE

Six-Minute Walk Test Enhanced by Mobile Telemetric Cardiopulmonary Monitoring

(2010) Claudia Tueller et al.   RESPIRATION

Sub-clinical left and right ventricular dysfunction in patients with COPD

(2010) Ramsey Sabit et al.   RESPIRATORY MEDICINE

Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension

(2009) Isabel Blanco et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Misclassification of Pulmonary Hypertension Due to Reliance on Pulmonary Capillary Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure

(2009) Scott D. Halpern et al.   CHEST

Impact of Pulmonary Artery Pressure on Exercise Function in Severe COPD

(2009) Michael W. Sims et al.   CHEST

Guidelines for the diagnosis and treatment of pulmonary hypertension

(2009) et al.   EUROPEAN RESPIRATORY JOURNAL

Iloprost Improves Gas Exchange and Exercise Tolerance in Patients with Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

(2009) Tarek A. Dernaika et al.   RESPIRATION

A randomised, controlled trial of bosentan in severe COPD

(2008) D. Stolz et al.   EUROPEAN RESPIRATORY JOURNAL

Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation

(2008) Andrea Aliverti et al.   JOURNAL OF APPLIED PHYSIOLOGY

Sildenafil treatment in COPD does not affect stroke volume or exercise capacity

(2007) H. Rietema et al.   EUROPEAN RESPIRATORY JOURNAL